Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:15 PM
Ignite Modification Date:
2025-12-24 @ 9:15 PM
NCT ID:
NCT06834204
Eligibility Criteria:
Inclusion Criteria:
* diagnosed with any of the following cancers \[Stage I-III\]: breast, prostate, urinary bladder, and endometrial in the past 6 months;
* being treated for cancer with curative intent;
* had initial patient visit at the cancer center in the last 3 months;
* are being treated for cancer with curative intent at the Rutgers Cancer Institute of New Jersey
* have ≥1 CVD risk factor (hypertension, hyperlipidemia or type II diabetes) prior to cancer diagnosis that requires medication management;
* currently receiving care from a primary care provider or willing to initiate seeing a new primary care provider upon enrollment;
* Speak English or Spanish
Exclusion Criteria:
* had myocardial infarction or stroke within the previous 1 year; (2) have heart failure with an ejection fraction \<30%; (3) have stage IV-V chronic kidney disease (eGFR \<30); or do not speak English or Spanish. Patients whose cancer progresses to metastatic disease during the course of the 18-month trial will be allowed to continue to participate unless they voluntarily withdraw
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06834204
Study Brief:
Protocol Section:
NCT06834204